-
-
-
-
-
-
-
Asia Broadband receives phase 2 equipment for Mexico facility
-
-
-
-
-
-
-
SK bioscience submits application for adjuvanted flu vaccine trial
-
-
-
-
-
-
-
Quince Therapeutics completes enrollment in phase 3 ataxia trial
-
-
-
-
-
-
-
Neurocrine shares registry data showing CAH treatment challenges
-
-
-
-
-
-
-
ZYUS Life Sciences appoints hematologist-oncologist as chief medical officer
-
-
-
-
-
-
-
Biodexa files CTA in Europe for Phase 3 FAP trial
-
-
-
-
-
-
-
Takeda reports positive phase 3 results for narcolepsy type 1 drug
-
71,209 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.